Publications & Works

Publication Network

Published journal articles indexed by SCI, SSCI, and AHCI

Discontinuing Omalizumab Treatment in Super-Responder Patients with Allergic Severe Asthma: Can the Baseline Total IgE Level Be Used as a Biological Marker to Decide Discontinuing Omalizumab Treatment?

ARSLAN B., PAÇACI ÇETİN G., Turk M., GÜLMEZ İ., YILMAZ İ.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, vol.183, no.10, pp.1071-1077, 2022 (SCI-Expanded) Creative Commons License identifier identifier identifier

Anti-IL5/IL5R switching between biologics in patients with severe eosinophilic asthma

YILMAZ İ., Çetin G. P., ARSLAN B.
Journal of Allergy and Clinical Immunology: In Practice, vol.10, no.7, pp.1935-1936, 2022 (SCI-Expanded) Creative Commons License identifier identifier identifier

Experience-based advice on stepping up and stepping down the therapeutic management of chronic spontaneous urticaria: Where is the guidance?

Turk M., YILMAZ İ., ŞAHİNER Ü. M., Kocaturk E., ŞEKEREL B. E., Zuberbier T., et al.
ALLERGY, vol.77, pp.1626-1630, 2022 (SCI-Expanded) identifier identifier identifier

Epithelial barrier hypothesis: Effect of external exposome on microbiome and epithelial barriers in allergic disease

Sozener Z. C., Ozturk B. O., Cerci P., Turk M., Akin B. G., Akdis M., et al.
ALLERGY, vol.77, no.5, pp.1418-1449, 2022 (SCI-Expanded) Sustainable Development identifier identifier identifier

Stable and exacerbation period serum cytokine and periostin levels of the five distinct phenotypes of severe asthma

TÜRK M., YILMAZ İ., GÖKAHMETOĞLU S., KOÇ A. N.
Turkish Journal of Medical Sciences, vol.52, no.4, pp.1148-1159, 2022 (SCI-Expanded) Creative Commons License identifier identifier identifier identifier

Venom immunotherapy and difficulties encountered before and during immunotherapy: Double sensitization, systemic reactions, treatment with omalizumab, and high dose VIT

PAÇACI ÇETİN G., YILMAZ İ., Turk M., ARSLAN B., Bahcecioglu S. N.
TURKISH JOURNAL OF MEDICAL SCIENCES, vol.52, no.4, pp.1223-1234, 2022 (SCI-Expanded) Creative Commons License identifier identifier identifier identifier

A case of hypersensitivity developing against trace element solution in total parenteral nutrition, proved by skin prick test

PAÇACI ÇETİN G., Turk M., Bahcecioglu S. N., YILMAZ İ.
EUROPEAN JOURNAL OF CLINICAL NUTRITION, vol.75, no.12, pp.1829-1831, 2021 (SCI-Expanded) identifier identifier identifier

Stable and exacerbation period serum cytokine and periostin levels of the five distinct phenotypes of severe asthma.

Türk M., Yilmaz İ., Gökahmetoğlu S., Koç A. N.
Turkish journal of medical sciences, 2021 (SCI-Expanded) Creative Commons License identifier

Current approach to the diagnosis of allergic bronchopulmonary aspergillosis

Turk M., NAZİK BAHÇECİOĞLU S., YILMAZ İ.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, vol.9, no.6, pp.2546, 2021 (SCI-Expanded) identifier identifier identifier

The Visible and Invisible Faces of the Iceberg of Type 2 Asthma

YILMAZ İ., PAÇACI ÇETİN G.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, vol.203, no.11, pp.1443-1444, 2021 (SCI-Expanded) identifier identifier identifier

High-Dose Omalizumab versus Ligelizumab for the Treatment of Chronic Spontaneous Urticaria: Do Not We Need a Head-To-Head Comparison?

Turk M., YILMAZ İ.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, vol.182, no.5, pp.461-462, 2021 (SCI-Expanded) identifier identifier

Worsening of chronic spontaneous urticaria after intake of hot pepper

TÜRK M., YILMAZ İ., Hawro T., Maurer M.
ASIAN PACIFIC JOURNAL OF ALLERGY AND IMMUNOLOGY, vol.39, no.1, pp.25-30, 2021 (SCI-Expanded) identifier identifier identifier

Effectiveness of as-needed antihistamines in chronic spontaneous urticaria patients under omalizumab treatment

TÜRK M., YILMAZ İ., NAZİK BAHÇECİOĞLU S., Can P., Ertas R., KARTAL D., et al.
DERMATOLOGIC THERAPY, vol.34, no.1, 2021 (SCI-Expanded) identifier identifier identifier

Frequency of peripheral blood eosinophilia and obstructive airway disease in sarcoidosis

Rabahoglu B., OYMAK F. S., Ketencioglu B. B., TUTAR N., GÜLMEZ İ., YILMAZ İ.
TURKISH JOURNAL OF MEDICAL SCIENCES, vol.51, no.6, pp.3001-3007, 2021 (SCI-Expanded) Creative Commons License identifier identifier identifier identifier

Type 2 chronic rhinosinusitis with nasal polyps: From phenotype to endotype

YILMAZ İ.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, vol.9, no.1, pp.600-601, 2021 (SCI-Expanded) identifier identifier identifier

Effectiveness of mepolizumab therapy on symptoms, asthma exacerbations, steroid dependence, and small airways in patients with severe eosinophilic asthma

YILMAZ İ., Nazik Bahcecioglu S., Turk M., TUTAR N., PAÇACI ÇETİN G., ARSLAN B.
TURKISH JOURNAL OF MEDICAL SCIENCES, vol.51, no.4, pp.1953-1959, 2021 (SCI-Expanded) identifier identifier identifier identifier

Careful Selection of Patients Is Required to Obtain Higher Potential Benefit From Mepolizumab Therapy

YILMAZ İ.
CHEST, vol.158, no.5, pp.2229-2230, 2020 (SCI-Expanded) Creative Commons License identifier identifier identifier

The protective effects of thymoquinone on lung damage caused by cigarette smoke

Yetkin N. A., Buyukoglan H., Sonmez M. F., TUTAR N., GÜLMEZ İ., YILMAZ İ.
BIOTECHNIC & HISTOCHEMISTRY, vol.95, no.4, pp.268-275, 2020 (SCI-Expanded) identifier identifier identifier

Biologics for oral corticosteroid-dependent asthma

YILMAZ İ.
ALLERGY AND ASTHMA PROCEEDINGS, vol.41, no.3, pp.151-157, 2020 (SCI-Expanded) identifier identifier identifier

The presence of underlying asthma should be investigated in patients diagnosed with ACE inhibitor induced cough

Yilmaz İ., Türk M., Baran K., Çetinkaya Z., Tutar N., Oymak F. S., et al.
Clinical Respiratory Journal, vol.14, no.4, pp.382-388, 2020 (SCI-Expanded) identifier identifier identifier

Efficacy of mepolizumab treatment in oral corticosteroid-dependent severe eosinophilic asthma patients with chronic rhinosinusitis with nasal polyps: single center, real life study

YILMAZ İ., TÜRK M., NAZİK BAHÇECİOĞLU S., TUTAR N., GÜLMEZ İ.
TURKISH JOURNAL OF MEDICAL SCIENCES, vol.50, no.2, pp.433-441, 2020 (SCI-Expanded) identifier identifier identifier

Horse allergen sensitivity and respiratory symptoms among horse farm workers

Baran Ketencioğlu B., Yilmaz İ., Tutar N., Gülmez İ., Oymak F. S.
Turkish Journal of Medical Sciences, vol.50, no.4, pp.910-916, 2020 (SCI-Expanded) identifier identifier identifier

Selection of Biologics for Type 2-High Asthma

YILMAZ İ.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, vol.200, no.6, pp.790-791, 2019 (SCI-Expanded) Creative Commons License identifier identifier identifier

How to discontinue omalizumab in chronic spontaneous urticaria?

TÜRK M., Maurer M., YILMAZ İ.
ALLERGY, vol.74, no.4, pp.821-824, 2019 (SCI-Expanded) identifier identifier identifier

Urticaria control test might misevaluate disease control in particular patients treated with omalizumab

TÜRK M., YILMAZ İ.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, vol.122, no.3, pp.342-343, 2019 (SCI-Expanded) identifier identifier identifier

Last station in the eosinophilic asthma with chronic rhinosinusitis and/or nasal polyposis march: Eosinophilic asthma with radiological findings associated with blood eosinophilia

YILMAZ İ., Bahcecioglu S. N., TÜRK M., TUTAR N., OYMAK F. S., GÜLMEZ İ.
JOURNAL OF ASTHMA, vol.56, no.2, pp.111-117, 2019 (SCI-Expanded) identifier identifier identifier

Selection of Biologics for Severe Type-2 Asthma

YILMAZ İ.
JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, vol.29, no.5, pp.399-400, 2019 (SCI-Expanded) Creative Commons License identifier identifier identifier

Two-week intervals during omalizumab treatment may provide better symptom control in selected patients with chronic urticaria

Turk M., Kocaturk E., Cure K., YILMAZ İ.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, vol.6, no.4, pp.1389-1390, 2018 (SCI-Expanded) identifier identifier identifier

Biologic Targeted Therapies for the Phenotypes of Type-2 High Severe Asthma

YILMAZ İ., Turk M.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, vol.6, no.3, pp.1091-1092, 2018 (SCI-Expanded) identifier identifier identifier

Treatment and retreatment with omalizumab in chronic spontaneous urticaria: Real life experience with twenty-five patients

Turk M., YILMAZ İ., Bahcecioglu S. N.
ALLERGOLOGY INTERNATIONAL, vol.67, no.1, pp.85-89, 2018 (SCI-Expanded) identifier identifier identifier

Comment on: "Targeting the PGD(2)/CRTH2/DP1 Signaling Pathway in Asthma and Allergic Disease: Current Status and Future Perspectives"

YILMAZ İ., Turk M.
DRUGS, vol.77, no.17, pp.1925-1926, 2017 (SCI-Expanded) identifier identifier identifier

What Should Be the Cutoff Value of Blood Eosinophilia as a Predictor of Inhaled Corticosteroid Responsiveness in Patients with Chronic Obstructive Pulmonary Disease?

YILMAZ İ., Turk M.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, vol.196, no.9, pp.1229-1230, 2017 (SCI-Expanded) identifier identifier identifier

Eosinophilic asthma with nasal polyposis march: Is aspirin-exacerbated respiratory disease the last station?

YILMAZ İ., Turk M., Bahcecioglu S. N.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, vol.5, no.6, pp.1807-1808, 2017 (SCI-Expanded) identifier identifier identifier

Asthma management: A new phenotype-based approach using presence of eosinophilia and allergy

YILMAZ İ.
ALLERGY, vol.72, no.10, pp.1587-1588, 2017 (SCI-Expanded) identifier identifier identifier

Classification of eosinophilic granulomatosis with polyangiitis phenotypes and treatment based on phenotypes

YILMAZ İ., Turk M., Bahcecioglu S. N.
AUTOIMMUNITY REVIEWS, vol.16, no.9, pp.992-993, 2017 (SCI-Expanded) identifier identifier identifier

Successful Desensitization in a Patient with Hypersensitivity Reaction to Laronidase

YILMAZ İ., SEZGİN ÇAĞLAR A., KARDAŞ F., ÖZDAMAR KARACA Z. C., YENİGÜN S., TUTAR N.
Pediatric Allergy Immunology And Pulmonology, vol.30, pp.64-66, 2017 (SCI-Expanded) identifier identifier

Comment on: “Targeting the PGD2/CRTH2/DP1 Signaling Pathway in Asthma and Allergic Disease: Current Status and Future Perspectives”

YILMAZ İ., TÜRK M.
Drugs, vol.77, pp.925-1926, 2017 (SCI-Expanded)

The Association of Brain-Derived Neurotrophic Factor Gene Polymorphism with Obstructive Sleep Apnea Syndrome and Obesity

Yuksekkaya M., TUTAR N., Buyukoglan H., DÜNDAR M., YILMAZ I., GÜLMEZ I., et al.
LUNG, vol.194, no.5, pp.839-846, 2016 (SCI-Expanded) Sustainable Development identifier identifier identifier

Evaluation of drug provocation teste-related anxiety in patients with drug hypersensitivity

Soyyigit S., Aydin O., Yilmaz I., Ozdemir S. K., Cankorur V. S., Atbasoglu C., et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, vol.117, no.3, pp.280-284, 2016 (SCI-Expanded) identifier identifier identifier

Turkish version of the Drug Hypersensitivity Quality of Life Questionnaire: assessment of reliability and validity

Bavbek S., Ozdemir S. K., Erdogan B. D., Karaboga I., Buyukozturk S., Gelincik A., et al.
QUALITY OF LIFE RESEARCH, vol.25, no.1, pp.101-109, 2016 (SCI-Expanded) identifier identifier identifier

Response to imatinib in patient with corticosteroid-unresponsive idiopatic hypereosinophilic syndrome

Yilmaz I., KAYNAR L., TUTAR N., PALA Ç., CANÖZ Ö., Buyukoglan H., et al.
REVISTA PORTUGUESA DE PNEUMOLOGIA, vol.22, no.1, pp.59-60, 2016 (SCI-Expanded) identifier

Evaluation of vascular endothelial growth factor-A and Endostatin levels in induced sputum and relationship to bronchial hyperreactivity in patients with persistent allergic rhinitis monosensitized to house dust

Yilmaz İ., Bayraktar N., Ceyhan K., Secil D., Yuksel S., Misirligil Z., et al.
REVISTA PORTUGUESA DE PNEUMOLOGIA, vol.21, no.6, pp.321-326, 2015 (SCI-Expanded) identifier identifier identifier

Is Serum Cystatin C a Predictor of Acute Pulmonary Thromboembolism in Patients With Normal Renal Function?

TUTAR N., KEMIK N. A., YILMAZ I., Buyukoglan H., KANBAY A., DOĞAN A., et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, vol.21, no.6, pp.533-538, 2015 (SCI-Expanded) identifier identifier identifier

Response of complex undefined hypereosinophilic syndrome to treatment with imatinib Churg Strauss syndrome in the differantial diagnosis

YILMAZ İ., KAYNAR L., TUTAR N., PALA Ç., CANÖZ Ö., BÜYÜKOĞLAN H., et al.
Allergy, vol.70, pp.396, 2015 (SCI-Expanded) identifier

Churg-Strauss syndrome: a new endotype of severe asthma? Results of 14 Turkish patients

Yilmaz I., Celik G., Aydin O., Ozdemir S. K., Soyyigit S., Sozener Z., et al.
CLINICAL RESPIRATORY JOURNAL, vol.9, no.3, pp.350-358, 2015 (SCI-Expanded) identifier identifier identifier

Drug allergy in tertiary care in Turkey: Results of a national survey. The ADAPT study: Adult drug allergy perception in Turkey

Celik G. E., KARAKAYA G., ÖZTÜRK A. B., Gelincik A., Abadoglu O., SİN A. Z., et al.
ALLERGOLOGIA ET IMMUNOPATHOLOGIA, vol.42, no.6, pp.573-579, 2014 (SCI-Expanded) identifier identifier identifier

Is serum cystatin C a predictor of acute pulmonary thromboembolism in patients with normal renal function?

Tutar N., Kemik N. A., Yilmaz İ., YAZICI C., Elmali F., Buyukoglan H., et al.
EUROPEAN RESPIRATORY JOURNAL, vol.44, 2014 (SCI-Expanded) identifier

Sensitization to pets in pet shop workers Reply

Yilmaz I., ERKEKOL F. O., Secil D., Misirligil Z., Mungan D.
OCCUPATIONAL MEDICINE-OXFORD, vol.64, no.6, pp.471, 2014 (SCI-Expanded) identifier identifier identifier

How do patients with asthma and COPD behave during fasting?

Aydin O., Celik G. E., Onen Z. P., Yilmaz I., Ozdemir S. K., Yildiz O., et al.
ALLERGOLOGIA ET IMMUNOPATHOLOGIA, vol.42, no.2, pp.115-119, 2014 (SCI-Expanded) identifier identifier identifier

Learning curve of conventional transbronchial needle aspiration

TUTAR N., Buyukoglan H., YILMAZ I., KANBAY A., ÖNAL Ö., BİLGİN M., et al.
CLINICAL RESPIRATORY JOURNAL, vol.8, no.1, pp.79-85, 2014 (SCI-Expanded) identifier identifier identifier

Non-Asbestos-related Malignant Pleural Mesothelioma

KANBAY A., SIMSEK Z. O., TUTAR N., YILMAZ I., Buyukoglan H., CANÖZ Ö., et al.
INTERNAL MEDICINE, vol.53, no.17, pp.1977-1979, 2014 (SCI-Expanded) Creative Commons License identifier identifier

Cat and dog sensitization in pet shop workers

Yilmaz I., ERKEKOL F. O., Secil D., Misirligil Z., Mungan D.
OCCUPATIONAL MEDICINE-OXFORD, vol.63, no.8, pp.563-567, 2013 (SCI-Expanded) identifier identifier identifier

Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease

TUTAR N., Metan G., Koc A. N., YILMAZ I., Bozkurt I., SIMSEK Z. O., et al.
MULTIDISCIPLINARY RESPIRATORY MEDICINE, vol.8, 2013 (SCI-Expanded) identifier identifier identifier

Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary diseases

TUTAR N., Metan G., KOÇ A. N., YILMAZ İ., Bozkurt I., Simsek Z. O., et al.
EUROPEAN RESPIRATORY JOURNAL, vol.42, 2013 (SCI-Expanded) identifier

Immediate-type hypersensitivity reactions to proton pump inhibitors: usefulness of skin tests in the diagnosis and assessment of cross-reactivity

Ozdemir S. K., Yilmaz I., Aydin O., Buyukozturk S., Gelincik A., Demirtürk M. O., et al.
ALLERGY, vol.68, no.8, pp.1008-1014, 2013 (SCI-Expanded) identifier identifier identifier

Coexistence of allergic bronchopulmonary aspergillosis and atopic dermatitis: Is total IgE level useful to identify relapses of allergic bronchopulmonary aspergillosis?

Yilmaz I., Aydin O., Ozdemir S. K., Mungan D., Celik G.
ALLERGOLOGIA ET IMMUNOPATHOLOGIA, vol.41, no.4, pp.281-283, 2013 (SCI-Expanded) identifier identifier identifier

Does drug compliance change in asthmatic patients during pregnancy?

Yilmaz I., ERKEKOL F. O., CELEN S., KARACA M. Z., Aydin O., Celik G., et al.
MULTIDISCIPLINARY RESPIRATORY MEDICINE, vol.8, 2013 (SCI-Expanded) Sustainable Development identifier identifier identifier

Evaluation of vascular endothelial growth factor A and endostatin levels in induced sputum and relationship to bronchial hyperreactivity in patients with seasonal allergic rhinitis

Yilmaz I., Bayraktar N., Ceyhan K., Secil D., Yuksel S., Misirligil Z., et al.
AMERICAN JOURNAL OF RHINOLOGY & ALLERGY, vol.27, no.3, pp.181-186, 2013 (SCI-Expanded) identifier identifier identifier

Fixed drug eruption caused by ornidazole and fluconazole but not isoconazole, itraconazole, ketoconazole and metronidazole

Bavbek S., Yilmaz I., Sozener Z. C.
JOURNAL OF DERMATOLOGY, vol.40, no.2, pp.134-135, 2013 (SCI-Expanded) identifier identifier identifier

Lung abscess: analysis of the results as community-acquired or nosocomial

TUTAR N., OYMAK F. S., Kanbay A., Buyukoglan H., YILDIRIM A., YILMAZ I., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES, vol.43, no.2, pp.255-262, 2013 (SCI-Expanded) identifier identifier

Late onset anaphylaxis in a hydatid cyst case presenting with chronic urticaria

YILMAZ İ., Aydin O., Okoh A., Misirligil Z.
Case Reports in Medicine, vol.2013, 2013 (SCI-Expanded) Creative Commons License identifier identifier

Triggers of asthma and COPD: Are they different?

Aydin O., Celik G. E., Onen Z. P., Yilmaz I., Ozdemir S. K., Yildiz O., et al.
ALLERGOLOGIA ET IMMUNOPATHOLOGIA, vol.41, no.1, pp.30-36, 2013 (SCI-Expanded) identifier identifier identifier

Asthma control test administered by web-based text messaging (short message service-SMS): Is it comparable with paper form?

Uysal M. A., Mungan D., Yorgancioglu A., Yildiz F., AKGÜN M., GEMİCİOĞLU B., et al.
EUROPEAN RESPIRATORY JOURNAL, vol.40, 2012 (SCI-Expanded) identifier

Prevalence of aspirin-exacerbated respiratory disease in patients with asthma in Turkey: A cross-sectional survey

Bavbek S., Yilmaz I., Celik G., Aydin O., Erkekol F. O., Orman A., et al.
ALLERGOLOGIA ET IMMUNOPATHOLOGIA, vol.40, no.4, pp.225-230, 2012 (SCI-Expanded) identifier identifier identifier

Pyrazinamide-Induced Anaphylaxis: Diagnosed by Skin Test and Successful Desensitization

Bavbek S., Yilmaz I., Aydin O., Ozdemir S. K.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, vol.157, no.2, pp.209-212, 2012 (SCI-Expanded) Sustainable Development identifier identifier identifier

Self-Reported Knowledge and Approaches Toward Complementary and Alternative Medicine Among Physicians Dealing with Allergic Diseases

ARGUDER E., Yilmaz I., Ates C., Misirligil Z., Bavbek S.
AMERICAN JOURNAL OF CHINESE MEDICINE, vol.40, no.4, pp.671-683, 2012 (SCI-Expanded) identifier identifier identifier

Therapy with omalizumab in patients with severe persistant allergic asthma: A real life data in Turkey Aǧir allerjik astimli hastalarda anti-IgE (omalizumab) tedavisi: Gerçek yaşam verileri

Bavbek S., Aydin Ö., Kepil Özdemir S., YILMAZ İ., Çelik G. E., Demirel Y. S., et al.
Tuberkuloz ve Toraks, vol.58, no.4, pp.425-434, 2010 (SCI-Expanded) identifier identifier

Attitudes and Knowledge for Smoking Among University Students

Akcay S., Dilektasli A. G., Budakoglu I., Yilmaz I., Erdem O.
TURKIYE KLINIKLERI TIP BILIMLERI DERGISI, vol.29, no.3, pp.611-617, 2009 (SCI-Expanded) Sustainable Development identifier identifier

Fire-eater's pneumonia after aspiration of liquid paraffin

Karacan Ö., YILMAZ İ., Eyüboǧlu F. Ö.
Turkish Journal of Pediatrics, vol.48, no.1, pp.85-88, 2006 (SCI-Expanded) identifier identifier identifier

Articles Published in Other Journals

Physical activity and dietary habits in patients with asthma: How is it related to asthma control?

AYDIN Ö., Çelebi Sözener Z., MUNGAN V. D., Özbey Ü., BALABAN S., GÖKMEN D., et al.
Obesity Medicine, vol.38, 2023 (Scopus) identifier

Mepolizumab-Related Adverse Events in Severe Eosinophilic Asthma: A Real-Life Study

NAZİK BAHÇECİOĞLU S., TURK M., ATAYIK E., PAÇACI ÇETİN G., ARSLAN B., GÜLMEZ İ., et al.
ASTIM ALLERJI IMMUNOLOJI, vol.20, no.2, pp.81-86, 2022 (ESCI) identifier identifier

The Management of Acute and Chronic Urticaria

YILMAZ İ., PAÇACI ÇETİN G., ARSLAN B., Turk M.
ASTIM ALLERJI IMMUNOLOJI, vol.20, no.3, pp.202-204, 2022 (ESCI) identifier identifier identifier

Classification of asthma severity: Severe/not severe asthma or mild/moderate/severe asthma?

YILMAZ İ., Cetin G. P., ARSLAN B.
TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX, vol.70, no.3, pp.300-301, 2022 (ESCI) Creative Commons License identifier identifier identifier identifier

Are we entering an era of combined biologic use for severe asthma?

ARSLAN B., ŞEKER S., YILMAZ İ.
Tuberkuloz ve Toraks, vol.70, no.4, pp.403-404, 2022 (ESCI) Creative Commons License identifier identifier identifier

Safety Profiles of Biological Therapies Used in Asthma Treatment

PAÇACI ÇETİN G., ARSLAN B., YILMAZ İ.
ASTIM ALLERJI IMMUNOLOJI, vol.20, no.3, pp.127-141, 2022 (ESCI) identifier identifier identifier

The adequacy of current diagnostic criteria for making a diagnosis of ABPA

Bahcecioglu S. N., Turk M., PAÇACI ÇETİN G., YILMAZ İ.
TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX, vol.70, no.2, pp.141-148, 2022 (ESCI) Creative Commons License identifier identifier identifier identifier

Asthma phenotype and endotype definitions

YILMAZ İ., PAÇACI ÇETİN G.
TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX, vol.69, no.2, pp.288-290, 2021 (ESCI) identifier identifier identifier identifier

Type 2 inflammation in asthma

YILMAZ İ., ARSLAN B.
TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX, vol.69, no.1, pp.114-115, 2021 (ESCI) identifier identifier identifier identifier

Blood hyperreosinophilia: A diagnostic challenge

PAÇACI ÇETİN G., KÖSE M., ARSLAN B., YILMAZ İ.
TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX, vol.69, no.3, pp.408-415, 2021 (ESCI) identifier identifier identifier identifier

Long-term macrolide therapy in asthma

PAÇACI ÇETİN G., Arslan B., YILMAZ İ.
TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX, vol.69, no.4, pp.520-534, 2021 (ESCI) Sustainable Development identifier identifier identifier identifier

A prospective observational evaluation of treatment outcomes of patients with chronic obstructive pulmonary disease and peripheral blood eosinophilia Kronik obstrüktif akciğer hastalığı ve periferik kan eozinofilisi olan hastaların tedavi sonuçlarının prospektif gözlemsel değerlendirilmesi

Tutar N., Arslantaş F., Baran Ketencioğlu B., Yılmaz İ., Oymak F. S., Gülmez İ.
Tuberkuloz ve Toraks, vol.69, no.4, pp.477-485, 2021 (ESCI) Creative Commons License identifier identifier identifier identifier

Non-Infectious Diseases Compatible With COVID-19 Pneumonia

BARAN KETENCİOĞLU B., YİĞİT F., Almadqa M., TUTAR N., YILMAZ İ.
CUREUS, vol.12, no.8, 2020 (ESCI) Sustainable Development identifier identifier

What Should the Optimal Adrenaline Auto-Injector Needle Length Be?

TÜRK M., Turk G., KOÇ A., KARABIYIK Ö., YILMAZ İ.
ASTIM ALLERJI IMMUNOLOJI, vol.18, no.2, pp.82-90, 2020 (ESCI) identifier

A Rare Case of Multiple Severe Anaphylaxis Caused by Thyme, Black Pepper, Wasp and Honey

TÜRK M., YILMAZ İ.
ASTIM ALLERJI IMMUNOLOJI, vol.17, no.2, pp.115-117, 2019 (ESCI) Creative Commons License identifier

Angiotensin-Converting Enzyme Inhibitors Induce Cough

YILMAZ İ.
Turkish Thoracic Journal, vol.20, no.1, pp.36-42, 2019 (ESCI) identifier identifier identifier

Eosinophilic asthma with chronic rhinosinusitis/nasal polyps and biologic agents

YILMAZ İ.
TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX, vol.67, no.4, pp.292-299, 2019 (ESCI) Creative Commons License identifier identifier identifier

Confusing Terminology: Difficult Asthma, Difficult-to-Treat Asthma, Difficult-to-Control Asthma, Therapy-Resistant Asthma, Severe Asthma, and Refractory Asthma. Which One is Truly Severe Asthma?

YILMAZ İ.
Turkish Thoracic Journal, vol.19, no.4, pp.235-236, 2018 (Scopus)

ATOPIK DERMATIT TANI VE TEDAVISINEYAKLAŞIM: ULUSAL REHBER 2018veÜRTIKER TANI VE TEDAVISIGÜNCEL DURUM RAPORU

AKSU K., ARGA M., ASİLSOY S., Avcıl S., Çetinkaya F., CİVELEK E., et al.
Astım Allerji İmmünoloji, vol.16, no.2, 2018 (Peer-Reviewed Journal)

Omalizumab Treatment for Atopic Severe Persistant Asthma: A Single-Center, Long-Term, Real-Life Experience with 38 Patients

TÜRK M., NAZİK BAHÇECİOĞLU S., TUTAR N., OYMAK F. S., GÜLMEZ İ., YILMAZ İ.
Turkish Thoracic Journal, vol.19, no.4, pp.187-192, 2018 (Scopus)

Is Asthma-COPD overlap an asthma phenotype or a COPD phenotype?

YILMAZ İ.
Tuberkuloz ve Toraks, vol.66, no.1, pp.78-79, 2018 (Scopus)

Local anesthetics allergy: who should be tested

YILMAZ İ., KEPİL ÖZDEMİR S., AYDIN Ö., ÇELİK G. E.
European Annals of Allergy and Clinical Immunology, 2018 (Scopus) identifier identifier

ATOPİK DERMATİT TANI VE TEDAVİSİNE YAKLAŞIM

AKSU K., ARGA M., ASİLSOY S., AVCİL S., ÇETİNKAYA F., CİVELEK E., et al.
Astım Allerji İmmunoloji, 2018 (Peer-Reviewed Journal)

Combination of omalizumab and bee venom immunotherapy: does it work?

YILMAZ İ., NAZİK BAHÇECİOĞLU S., TÜRK M.
Asia Pacific Allergy, vol.8, no.1, pp.2, 2018 (ESCI)

Successful rapid subcutaneous desensitization to anakinra in a case with a severe immediate-type hypersensitivity reaction

YILMAZ İ., TÜRK M., NAZİK BAHÇECİOĞLU S.
European Annals of Allergy and Clinical Immunology, vol.50, no.2, pp.94, 2017 (Scopus)

Is nonhomogeneous expression of tissue mast cells or allergen specific IgEs bound to tissue mast cells possible?

Turk M., Bahcecioglu S. N., YILMAZ İ.
ASIA PACIFIC ALLERGY, vol.7, no.3, pp.179-181, 2017 (ESCI) identifier identifier

Clinical and Serological Features of Eosinophilic and Vasculitic Phases of Eosinophilic Granulomatosis with Poliangiitis: a Case Series of 15 Patients

Yilmaz I., TUTAR N., Simsek Z. O., OYMAK F. S., GÜLMEZ I.
TURKISH THORACIC JOURNAL, vol.18, no.3, pp.72-77, 2017 (ESCI) Creative Commons License identifier identifier identifier

Ranitidine-Induced Anaphylaxis in a Patient with Acute COPD Exacerbation

YILMAZ İ., TÜRK M.
TURKISH THORACIC JOURNAL, vol.18, pp.94-95, 2017 (ESCI) Creative Commons License identifier identifier identifier

Tenoxicam-Induced Fixed Drug Eruption Confirmed by Skin Patch Test

Yilmaz I., TUTAR N., Yenigun S., Simsek Z. O., GÜLMEZ I.
ASTIM ALLERJI IMMUNOLOJI, vol.15, no.3, pp.162-164, 2017 (ESCI) Creative Commons License identifier

A Baker with Asthma and Wheat Flour Food Allergy

Yilmaz I., Mungan D.
ASTIM ALLERJI IMMUNOLOJI, vol.15, no.2, pp.107-110, 2017 (ESCI) Creative Commons License identifier

Response of Complex Undefined Hypereosinophilic Syndrome to Treatment with Imatinib

Yilmaz I., KAYNAR L., TUTAR N., PALA C., CANÖZ Ö., Yıldırım A., et al.
TURKISH THORACIC JOURNAL, vol.17, no.3, pp.118-121, 2016 (ESCI) Creative Commons License identifier

İlaç Reaksiyonlarında Altta Yatan Mekanizmalar

YILMAZ İ.
Türkiye Klinikleri İmmünoloji Allerji Özel Dergisi, 2015 (Peer-Reviewed Journal)

The role of extracellular matrix in lung diseases

Derya M., YILMAZ I., Aytekin M.
European Journal of Physical and Health Education, vol.6, no.2, 2014 (Scopus) Creative Commons License identifier

Peripartum genital tuberculosis presenting with ascites

Dogan S., Celikbilek M., Topaloglu U. S., CANÖZ Ö., YILMAZ İ., Yurci A., et al.
Clinical Journal of Gastroenterology, vol.7, no.1, pp.27-31, 2014 (Scopus) Sustainable Development identifier identifier

[Strongyloides stercoralis hyperinfection syndrome in a patient with Behçet's Disease]. Behçet Hastasinda Strongyloides stercoralis Hiperenfeksiyon Sendromu.

YILMAZ İ., Caǧlar B., Akay B. N., Alkiz G., Boyvat A., Akyol A.
Türkiye parazitolojii dergisi / Türkiye Parazitoloji Derneǧi = Acta parasitologica Turcica / Turkish Society for Parasitology, vol.37, no.2, pp.139-142, 2013 (Scopus) Creative Commons License Sustainable Development identifier identifier

The frequency of asymptomatic atopy and relationship to latent tuberculosis in health workers

YILMAZ İ., Akcay S., Tusrkkan O., Bozkurt B.
ASTIM ALLERJI IMMUNOLOJI, vol.11, no.1, pp.43-48, 2013 (ESCI) Sustainable Development identifier

Idiopathic anaphylaxis: hereditary angioedema in the differential diagnosis

YILMAZ İ., TUTAR N., Buyukoglan H., GÜLMEZ İ., Oymak S., Demir R.
ASTIM ALLERJI IMMUNOLOJI, vol.11, no.1, pp.53-58, 2013 (ESCI) identifier

Biphasic anaphylaxis to gemifloxacin

YILMAZ İ., Dogan S., TUTAR N., Kanbay A., Buyukoglan H., Demir R.
ASIA PACIFIC ALLERGY, vol.2, no.4, pp.280-282, 2012 (ESCI) Creative Commons License identifier identifier

Therapy with omalizumab in patients with severe persistant allergic asthma: a real life data in Turkey

BAVBEK S., AYDIN Ö., Ozdemir S. K., YILMAZ İ., ÇELİK G. E., DEMİREL Y. S., et al.
TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX, vol.58, no.4, pp.425-434, 2010 (ESCI) identifier identifier identifier

Refereed Congress / Symposium Publications in Proceedings

False positive PET CT in non-malignant pulmonary lesions

TUTAR N., Yenigün S., OYMAK F. S., YILMAZ İ., GÜLMEZ İ.
Imaging, 28 September - 02 October 2019 identifier

What should the ideal adrenaline auto-injector needle length be?

TÜRK M., Turk G., Koc A., Karabiyik Ö., YILMAZ İ.
Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI), Lisbon, Portugal, 1 - 05 June 2019, vol.74, pp.144-145 identifier

Worsening of chronic spontaneous urticaria after intake of hot pepper

Turk M., YILMAZ İ., Maurer M.
Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI), Lisbon, Portugal, 1 - 05 June 2019, vol.74, pp.612-613 identifier

ASTIM HASTALARINDA FIZIKSEL AKTIVITEVE BESLENME TUTUM VE DAVRANIŞLARINBELIRLENMESI VE ASTIM KONTROLÜ ILEILIŞKISININ DEĞERLENDIRILMESI: ULUSAL ÇOKMERKEZLI BIR ARAŞTIRMA VERILERI

AYDIN Ö., ÇELEBİ SÖZENER Z., MUNGAN V. D., Yıldız F., ARGUN BARIŞ S., GEMİCİOĞLU B., et al.
TÜRK TORAKS DERNEĞİ ULUSLARARASI KATILIMLI 22. YILLIK KONGRESİ, Antalya, Turkey, 10 - 14 April 2019, pp.90

Astım hastalarında fiziksel aktivite ve beslenme tutum ve davranışların belirlenmesi ve astım kontrolü ile ilişkisinin değerlendirilmesi: ulusal çok merkezli bir araştırma verileri

AYDIN Ö., ÇELEBİ SÖZENER Z., MUNGAN V. D., yıldız F., BARIŞ S., GEMİCİOĞLU B., et al.
Türk Toraks Derneği 22. Ulusal Kongresi, Turkey, 10 - 14 April 2019

Astım hastalarında fiziksel aktivite ve beslenme tutum ve davranışların belirlenmesi ve astım kontrolü ile ilişkisinin değerlendirilmesi: Ulusal çok merkezli bir araştırma verileri

AYDIN Ö., ÇELEBİ SÖZENER Z., MUNGAN V. D., YILDIZ F., ARGUN BARIŞ S., GEMİCİOĞLU B., et al.
Türk Toraks Derneği 22. Yıllık Kongresi, 10 - 14 April 2019

Exacebation of chronic spontaneous urticaria after intake of hot pepper

TÜRK M., YILMAZ İ., maurer m.
Global Urticaria Forum, Berlin, Germany, 5 - 06 December 2018

How to discontinue omalizumab in chronic spontaneous urticaria?

TÜRK M., maurer m., YILMAZ İ.
Global Urticaria Forum, Berlin, Germany, 5 - 06 December 2018 identifier

Adrenalin otoenjektor iğne uzunluğu erişkin hastalar için yeterli midir?

TÜRK M., türk g., koç a., KARABIYIK Ö., YILMAZ İ.
25 yıllık allerji immünoloji kongresi, Antalya, Turkey, 17 - 21 November 2018

Acı biber tüketimi kronik spontan ürtikerli hastalarda semptom kontrolünü bozar mı?

TÜRK M., YILMAZ İ., maurer m.
25. ulusal allerji immünoloji kongresi, Antalya, Turkey, 17 - 21 November 2018

Kronik spontan ürtikerde omalizumab tedavisinin sonlandırılması: Gerçek yaşam deneyimi

TÜRK M., maurer m., YILMAZ İ.
25. ulusal allerji immünoloji kongresi, Antalya, Turkey, 17 - 21 November 2018

Omalizumab tedavi aralığının sonlarına doğru semptom artışı olan hastalarda, ürtiker kontrol testi hastalık kontrolünü yanlış değerlendiriyor olabilir mi?

TÜRK M., YILMAZ İ.
25. ıllık ulusal allerji immünolji kongresi, 17 - 21 November 2018

ADRENALİN OTOENJEKTÖR İĞNE UZUNLUĞU ERİŞKİN HASTALAR İÇİN YETERLİ MİDİR?

TÜRK M., TÜRK G., KOÇ A., KARABIYIK Ö., YILMAZ İ.
25. ULUSAL ALERJİ VE KLİNİK İMMÜNOLOJİ KONGRESİ, Turkey, 17 - 21 November 2018

THE ASSOCIATION OF BRAIN-DERIVED NEUROTROPHIC FACTOR GENE POLYMORPHISM WITH OBSTRUCTIVE SLEEP APNEA SYNDROME and OBESITY

TUTAR N., yüksekkaya m., DÜNDAR M., YILMAZ İ., GÜLMEZ İ., OYMAK F. S., et al.
european respiratory society congress 2018, 15 - 19 September 2018 Sustainable Development identifier

Last station in the eosinophilic asthmawith chronic rhinosinusitis and or nasal polyposismarch: Eosinophilic asthma with radiologicalfindings associated with blood eosinophilia

YILMAZ İ., NAZİK BAHÇECİOĞLU S., TÜRK M., TUTAR N., OYMAK F. S., GÜLMEZ İ.
EAACI Annual Congress 2018, Munich, Germany, 26 - 30 May 2018, vol.73

Ranitidine-Induced Anaphylaxis in a Patient with Acute COPD Exacerbation

YILMAZ İ., TÜRK M.
Türk Toraks Derneği Yıllık Kongresi 2018, 11 - 15 April 2018, vol.19

Omalizumab Treatment in Atopic Severe Persistant Asthma: a Single Center Real-Life Experience with Thirty Eight Patients

TÜRK M., NAZİK BAHÇECİOĞLU S., TUTAR N., OYMAK F. S., GÜLMEZ İ., YILMAZ İ.
Türk Toraks Derneği Yıllık Kongresi 2018, 11 - 15 April 2018, vol.19

Last Station in the Eosinophilic Asthma with Chronic Rhinosinusitis and/or Nasal Polyposis March: Eosinophilic Asthma with Thorax CT Findings Associated with Blood Eosinophilia

YILMAZ İ., NAZİK BAHÇECİOĞLU S., TÜRK M., TUTAR N., OYMAK F. S., GÜLMEZ İ.
Türk Toraks Derneği Yıllık KOngresi 2018, 11 - 15 April 2018, vol.19

vücut kitle indeksinden bağımsız olarak akut pulmoner tromboembolisi olan ve olmayan hastalarda serum visfatin seviyesinin karşılaştırılması

TUTAR N., doğan s., yetkin n. a., şen a., YILMAZ İ., DOĞAN A., et al.
uask 2018, Turkey, 14 - 18 March 2018

organize pnömoni yanlış pozitifliği saptanan olgular

dirim n., TUTAR N., YILMAZ İ., OYMAK F. S., GÜLMEZ İ.
uask2018, Turkey, 14 - 18 March 2018

Proton pompa inhibitörlerine bağlı erken tip aşırı duyarlılık reaksiyonlarında tanısal deri testi pozitifliği ile ilişkili faktörlerin analizi.

KEPİL ÖZDEMİR S., GELİNCİK A., ÖNER ERKEKOL F., KARAKAYA G., DURSUN A. B., YILMAZ İ., et al.
XIV. Ulusal Allerji ve Klinik İmmunoloji Kongresi, Turkey, 18 - 22 November 2017 Sustainable Development

Proton pompa inhibitörlerine bağlı erken tip aşırı duyarlılık reaksiyonlarında tanısal deri testi pozitifliği ile ilişkili faktörlerin analizi. (P-029)

KEPİL ÖZDEMİR S., GELİNCİK A., ÖNER ERKEKOL F., KARAKAYA G., DURSUN A. B., YILMAZ İ., et al.
24. Ulusal Allerji ve Klinik Immunoloji Kongresi, Antalya, Turkey, 18 - 22 November 2017, pp.29 Sustainable Development

The protective effects of thymoquinone on lung damage developed by cigarette smoke

yetkin N. A., BÜYÜKOĞLAN H., sönmez m. f., TUTAR N., YILMAZ İ., GÜLMEZ İ.
European-Respiratory-Society (ERS) International Congress, Milan, Italy, 9 - 13 September 2017, vol.50 identifier

A patient worsening with acute COPDexacerbation treatment

YILMAZ İ., TÜRK M.
EAACI Congress 2017, 17 - 21 June 2017

Treatment and retreatment withomalizumab in chronic spontaneous urticaria:real life experience with twenty-five patients

TÜRK M., YILMAZ İ., NAZİK BAHÇECİOĞLU S.
EAACI Congress 2017, 17 - 21 June 2017 identifier

Do patients who develop cough after initiation of angiotensin converting enzyme inhibitors have Asthma?

YILMAZ İ., Baran K. B., ÇETİNKAYA Z., TUTAR N., GÜLMEZ İ., OYMAK F. S., et al.
Congress of the European-Academy-of-Allergy-and-Clinical-Immunology, Helsinki, Finland, 17 - 21 June 2017, vol.72, pp.381-382 identifier

Successful Desensitization in a Patient with Hypersensitivity Reaction to Laronidase

YILMAZ İ., SEZGİN ÇAĞLAR A., KARDAŞ F., ÖZDAMAR KARACA Z. C., yenigün s., TUTAR N.
Congress of the European-Academy-of-Allergy-and-Clinical-Immunology, 17 - 21 June 2017 identifier

A patient worsening with acute COPD exacerbation treatment

YILMAZ İ., Turk M.
Congress of the European-Academy-of-Allergy-and-Clinical-Immunology, Helsinki, Finland, 17 - 21 June 2017, vol.72, pp.460 identifier

Who admitted for testing with local anesthetics and who should be tested

YILMAZ İ., AYDIN Ö., KEPİL ÖZDEMİR S., ÇELİK G. E.
Avrupa Allerji Kongresi, 11 - 15 June 2016 identifier

Malignite Dışı Akciğer Lezyonlarında PET BT Yanlış Pozitifliği.

TAŞAN S., OYMAK F. S., TUTAR N., GÜLMEZ İ., BÜYÜKOĞLAN H., YILMAZ İ., et al.
Toraks Derneği 19. Yıllık Kongresi, Antalya, Turkey, 6 - 10 April 2016

The comparison of serum visfatin levels in patients with acute PTE and non PTE independent of BMI

TUTAR N., doğan s., BÜYÜKOĞLAN H., şen a., YILMAZ İ., YILDIRIM A., et al.
ers international congress, 3 - 07 October 2015 identifier

Response of complex undefined hypereosinophilic syndrome to treatment with imatinib: Churg-Strauss syndrome in the differantial diagnosis

YILMAZ I., KAYNAR L., TUTAR N., PALA Ç., CANÖZ Ö., Buyukoglan H., et al.
Congress of the European-Academy-of-Allergy-and-Clinical-Immunology, Barcelona, Spain, 6 - 10 June 2015, vol.70, pp.396 identifier

Evaluation of drug provocation test related anxiety and possible related factors caused in patients with drug hypersensitivity

SOYYİĞİT Ş., AYDIN Ö., YILMAZ İ., ÖZDEMİR S., Cankorur V. S., Atbasoglu C., et al.
Congress of the European-Academy-of-Allergy-and-Clinical-Immunology, Barcelona, Spain, 6 - 10 June 2015, vol.70, pp.269 identifier

Turkish version of the drug hypersensitivity quality of life questionnaire: assessment of reliability and validity

BAVBEK S., Ozdemir K. S., Erdogan D. B., Karaboga I., Buyukozturk S., GELİNCİK A., et al.
Congress of the European-Academy-of-Allergy-and-Clinical-Immunology, Barcelona, Spain, 6 - 10 June 2015, vol.70, pp.249-250 identifier

Response of complex undefined hypereosinophilic syndrome to treatment with imatinib Eosinophilic lung diseases in the differential diagnosis

YILMAZ İ., KAYNAR L., TUTAR N., CANÖZ Ö., BÜYÜKOĞLAN H., GÜLMEZ İ.
EAACI Congress 2015, 6 - 10 June 2015

Eosinophilic phase of Churg Strauss syndrome or new asthma endotype

YILMAZ İ., TUTAR N., YILDIRIM A., BÜYÜKOĞLAN H., OYMAK F. S., GÜLMEZ İ., et al.
EAACI Congress 2015, 6 - 10 June 2015 identifier

Response of complex undefined hypereosinophilic syndrome to treatment with imatinib: Churg-Strauss syndrome in the differantial diagnosis

YILMAZ İ., KAYNAR L., TUTAR N., PALA Ç., CANÖZ Ö., BÜYÜKOĞLAN H., et al.
European Academy of Allergy and Clinical Immunology Congress, Barcelona, Spain, 6 - 10 June 2015, vol.70, pp.396

Allerjik bronkopulmoner aspergillozis (ABPA)

YILDIRIM A., DOĞAN S., ŞENOL S., YILMAZ İ., İMAMOĞLU H.
34. Ulusal Radyoloji Kongresi, Turkey, 6 - 10 November 2013

Biphasic anaphylaxis to gemifloxacin

YILMAZ I., DOĞAN S., TUTAR N., KANBAY A., Buyukoglan H., DEMIR R.
World Allergy and Asthma Congress of the European-Academy-of-Allergy-and-Clinical-Immunology and World-Allergy-Organization, Milan, Italy, 22 - 26 June 2013, vol.68, pp.217 identifier identifier

Usefulness of skin tests for the diagnosis of immediate type hypersensitivity reactions to proton pump inhibitors

ÖZDEMİR K., YILMAZ İ., AYDIN Ö., Buyukozturk S., GELİNCİK A., Demirturk M., et al.
World Allergy and Asthma Congress of the European-Academy-of-Allergy-and-Clinical-Immunology and World-Allergy-Organization, Milan, Italy, 22 - 26 June 2013, vol.68, pp.28 identifier

Learning curve of conventional transbronchial needle aspiration

TUTAR N., BÜYÜKOĞLAN H., YILMAZ İ., KANBAY A., ÖNAL Ö., BİLGİN M., et al.
2nd European Congress for Bronchology and Interventional Pulmonology., İzmir, Turkey, 27 - 30 April 2013

Atopy and workplace related symptoms among pet shop workers

YILMAZ İ., Erkekol O. F., Kazimova A., HARMANCI K., Misirligil Z., Mungan D.
30th Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI), İstanbul, Turkey, 11 - 15 June 2011, vol.66, pp.695 identifier

Therapy with omalizumab in patients with severe persistant allergic asthma: real life data in Turkey

BAVBEK S., AYDIN Ö., ÖZDEMİR K., YILMAZ İ., ÇELİK G., DEMİREL Y. S., et al.
30th Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI), İstanbul, Turkey, 11 - 15 June 2011, vol.66, pp.366 identifier

Vascular endothelial growth factor and Endostatin levels in induced sputum, and their relationship to bronchial hyperreactivity in patients with perennial allergic rhinitis

YILMAZ İ., Bayraktar N., CEYHAN K., Secil D., YÜKSEL S., DEMİREL Y. S., et al.
30th Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI), İstanbul, Turkey, 11 - 15 June 2011, vol.66, pp.692-693 identifier

Anaphylaxis to pyrazinamide: skin test positivity and successful desensitisation

BAVBEK S., YILMAZ İ., AYDIN Ö., ÖZDEMİR K.
30th Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI), İstanbul, Turkey, 11 - 15 June 2011, vol.66, pp.598 identifier

Does drug compliance change in asthmatic patients during pregnancy?

YILMAZ İ., Erkekol O. F., Celen S., Karaca Z. M., AYDIN Ö., ÇELİK G., et al.
30th Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI), İstanbul, Turkey, 11 - 15 June 2011, vol.66, pp.580 identifier

Triggers of COPD: Are they different from asthma?

AYDIN Ö., ÇELİK G., ÖNEN Z. P., YILMAZ İ., ÖZDEMİR S., YILDIZ Ö., et al.
30th Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI), İstanbul, Turkey, 11 - 15 June 2011, vol.66, pp.368 identifier

Evaluation of vascular remodeling in induced sputum and relationship to bronchial hyperreactivity in patients with seasonal allergic rhinitis

YILMAZ İ., Secil D., YÜKSEL S., Misirligil Z., DEMİREL Y. S., BAVBEK S.
29th Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI), London, Canada, 5 - 09 June 2010, vol.65, pp.725 identifier

Books & Book Chapters

COVID-19 Aşıları ile İlişkili Anafilaksi ve Alerjik Reaksiyonlar

Arslan B., Yılmaz İ.
in: COVID-19 ve Allerjik Hastalıklar , Şadan Soyyiğit, Editor, Türkiye Klinikleri Yayınevi, Ankara, pp.19-26, 2022 Sustainable Development

Astımın Kronik Tedavisi - Basamak Tedavisi 2022 Güncellemesi

Yılmaz İ.
in: Astımın Kronik Tedavisi - Basamak Tedavisi 2022 Güncellemesi, Prof. Dr. Gülfem E. ÇELİK, Editor, BULUŞ Tasarım ve Matbaacılık , Ankara, pp.1-38, 2022

BRONKOPROVOKASYON TESTLERİNİN KLİNİK KULLANIMI

Paçacı Çetin G., Yılmaz İ.
in: Solunum Fonksiyon Testleri: Klinik Uygulamalar, Sevgi Saryal,Öznur Yıldız, Editor, Türkiye Klinikleri Yayınevi, Ankara, pp.28-34, 2022

Anafilaksi

Paçacı Çetin G., Yılmaz İ.
in: Güncel Klavuzlar Eşliğinde İç Hastalıkları , Aydın Çiftci, Editor, Hipokrat , Ankara, pp.2728-2733, 2022

Yılmaz İ.
Dünya Tıp Kitabevi, Ankara, 2021

Egzersize bağlı bronkokonstriksiyon: patogenezden tanı yöntemlerine

Paçacı Çetin G., Yılmaz İ.
in: Sporcularda Alerjik Hastalıklar, Adile Berna Dursun, Editor, Türkiye Klinikleri Yayınevi, Ankara, pp.11-21, 2021

Bronş Provokasyon Testleri

Yılmaz İ.
in: GÖĞÜS HASTALIKLARI TANI ve TEDAVİ EL KİTABI, Prof. Dr. Mehmet Karadağ Prof. Dr. Akın Kaya Prof. Dr. Tevfik Özlü, Editor, BİLİMSEL TIP YAYINEVİ, Ankara, pp.82-89, 2021

ZOR ASTIM

Yılmaz İ.
in: GÖĞÜS HASTALIKLARI TANI ve TEDAVİ EL KİTABI, Prof. Dr. Mehmet Karadağ Prof. Dr. Akın Kaya Prof. Dr. Tevfik Özlü, Editor, Bilimsel Tıp Yayınevi, Ankara, pp.295-303, 2021

Astım Tanı ve Tedavi Rehberi 2020 Güncellemesi

Yılmaz İ.
in: Astım Tanı ve Tedavi Rehberi 2020 Güncellemesi, Gülfem E. ÇELİK, Editor, BULUŞ Tasarım ve Matbaacılık, Ankara, pp.1-5, 2020

Anafilaksi

Türk M., Yılmaz İ.
in: Bütüncül Tıp; Aile Hekimliğinde Güncel Tanı-Tedavi, Aydın Çiftçi, Editor, Nobel Yayın Dağıtım, Ankara, pp.459-461, 2020

Gelecekte Planlanan Biyolojik Astım Tedavileri

Yılmaz İ.
in: Alerjik Hastalıkların Tedavisinde Biyolojik Ajanlar, Mustafa Güleç, Editor, Türkiye Klinikleri Yayınevi, Ankara, pp.23-28, 2019

Proton pompa inhibitörü allerjileri; Antikoagülan allerjileri; Demir preparatları allerjileri; Aşı allerjileri; Flukonazol allerjisi; Allopürinol allerjisi; İntravenöz immünooglobülin allerjisi

Yılmaz İ.
in: İlaç aşırı duyarlılık reaksiyonlarına yaklaşım. Ulusal rehber 201, Gülfem E. Çelik, Editor, Buluş Matbaacılık, Ankara, pp.1-20, 2019

Solunum sitolojisi

ÜRER H. N., KAYA A., ÖZLÜ T., ÇETİNKAYA E., SAVAŞ R., bayram m., et al.
in: Göğüs Hastalıkları Propedötik, Mehmet Karadağ Akın Kaya Tevfik Özlü, Editor, Dünya Tıp Kitapevi, Ankara, pp.291-308, 2019

Allerji Tanısı

Türk M., Yılmaz İ.
in: Göğüs Hastalıkları Propedötik, Mehmet Karadağ,Akın Kaya Tevfik Özlü, Editor, Dünya tıp Kitabevi, Ankara, pp.321-331, 2019

Ağır/Zor Atopik Dermatit Tedavisi

Yılmaz İ.
in: Atopik Dermatit Tanı veTedavisinde Yaklaşım, Koray Harmancı, Editor, BULUŞ Tasarım ve Matbaacılık Hizmetleri, Ankara, pp.53-54, 2018

Bronş Provokasyon Testleri

YILMAZ İ.
Dünya Tıp Kitabevi, 2017

Bronş provokasyon testleri

Yılmaz İ.
in: Solunum Fizyolojisi ve Fizyopatolojisi , Gaye Ulabay,Elif Küpeli,Muzaffer Metintaş, Editor, İstanbul Tıp Kitabevler, İstanbul, pp.1-30, 2017

İlaç Reaksiyonlarında Altta Yatan Mekanizmalar

Yılmaz İ.
in: İlaç Allerjileri, Aytül Sin, Editor, Türkiye Klinikleri Yayınevi, Ankara, pp.1-7, 2015

Astım ve üst solunum yolu patolojileri

Yılmaz İ.
in: Göğüs Hastalıkları Uzmanları için Allerji , Gül Karakaya,Kıvılcım Oğuzülgen, Editor, Atalay Konf. Matbaa ve Rekn İnş, Ankara, pp.1-5, 2015

Noktürnal Astım

Yılmaz İ.
in: Özel ve Eşlik Eden Durumlarda Astım, Osman ŞENER, Editor, Türkiye Solunum Araştırmaları Derneği, Ankara, pp.1-9, 2014

Other Publications

Zor Astım

Yılmaz İ.
Other, pp.30-40, 2021

Mikrobiyom ve Astım

Arslan B., Yılmaz İ.
Other, pp.15-27, 2020

Astımda Kişiye Özgü Tedavi: Biyolojik Ajanlardan Kimler Fayda Görür?

Yılmaz İ.
Other, pp.25-28, 2017